These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 112867)

  • 1. Premature onset of labor, neonatal patent ductus arteriosus, and prostaglandin synthetase antagonists--a rat model of a human problem.
    Altshuler G; Krous HF; Altmiller DH; Sharpe GL
    Am J Obstet Gynecol; 1979 Sep; 135(2):261-5. PubMed ID: 112867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent ductus arteriosus after prolonged treatment with indomethacin during pregnancy: case report.
    Atad J; Lissak A; Rofe A; Abramovici H
    Int J Gynaecol Obstet; 1987 Feb; 25(1):73-6. PubMed ID: 2883050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug induced closure of patent ductus arteriosus.
    Archer N
    Heart; 1996 Nov; 76(5):384-5. PubMed ID: 8944580
    [No Abstract]   [Full Text] [Related]  

  • 4. Preterm parturition. Prostaglandin synthetase inhibitors.
    Niebyl JR
    Semin Perinatol; 1981 Jul; 5(3):274-87. PubMed ID: 6792710
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome.
    Csaba IF; Sulyok E; Ertl T
    J Pediatr; 1978 Mar; 92(3):484. PubMed ID: 632996
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed neonatal closure of the ductus arteriosus following early in utero exposure to indomethacin in the rat.
    Momma K; Toyoshima K; Ito K; Sugiyama K; Imamura S; Sun F; Nakanishi T
    Neonatology; 2009; 96(2):69-79. PubMed ID: 19225238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of arachidonic acid metabolism in the perinatal period: pharmacology, clinical application, and potential adverse effects.
    Witter FR; Niebyl JR
    Semin Perinatol; 1986 Oct; 10(4):316-33. PubMed ID: 3105069
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus.
    Loftin CD; Trivedi DB; Langenbach R
    J Clin Invest; 2002 Aug; 110(4):549-57. PubMed ID: 12189249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal, fetal, and neonatal physiology in pregnancy.
    Gilbert WM
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):4-7. PubMed ID: 2102303
    [No Abstract]   [Full Text] [Related]  

  • 10. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus.
    Moise KJ; Huhta JC; Sharif DS; Ou CN; Kirshon B; Wasserstrum N; Cano L
    N Engl J Med; 1988 Aug; 319(6):327-31. PubMed ID: 3393194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of premature labor with indomethacin and its effect on the fetus].
    Sturc M; Turek J; Wawreczka K
    Cesk Gynekol; 1982 Dec; 47(10):751-3. PubMed ID: 7159946
    [No Abstract]   [Full Text] [Related]  

  • 14. Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe.
    Levin DL; Mills LJ; Parkey M; Garriott J; Campbell W
    J Pediatr; 1979 Apr; 94(4):647-50. PubMed ID: 430314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal reversed constrictive effect of indomethacin and postnatal delayed closure of the ductus arteriosus following administration of transplacental magnesium sulfate in rats.
    Toyoshima K; Momma K; Nakanishi T
    Neonatology; 2009; 96(2):125-31. PubMed ID: 19279396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PG-synthetase inhibitors in obstetrics and after.
    Lancet; 1980 Jul; 2(8187):185-6. PubMed ID: 6105344
    [No Abstract]   [Full Text] [Related]  

  • 17. Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course.
    Ben-David Y; Hallak M; Rotschild A; Sorokin Y; Auslender R; Abramovici H
    Fetal Diagn Ther; 1996; 11(5):341-4. PubMed ID: 8894629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal and neonatal effects of indomethacin used as a tocolytic agent.
    Dudley DK; Hardie MJ
    Am J Obstet Gynecol; 1985 Jan; 151(2):181-4. PubMed ID: 3970083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants.
    Kim ES; Kim EK; Choi CW; Kim HS; Kim BI; Choi JH; Park JS; Moon KC
    J Pediatr; 2010 Nov; 157(5):745-50.e1. PubMed ID: 20598319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.